ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag european union immunology genetics genomics

Toward a “Clickable Plant”
Jane Salodof Macneil | Feb 15, 2004 | 9 min read
By conscious design, plant genomics initiatives have devoted initial resources to new technology development. Part of that money went to developing functional genomics approaches, and part to new sequencing technologies.
Going Viral
Breeann Kirby and Jeremy J. Barr | Sep 1, 2013 | 10+ min read
From therapeutics to gene transfer, bacteriophages offer a sustainable and powerful method of controlling microbes.
Green Gene Advocates Await Climate Change
Martina Habeck | Sep 29, 2002 | 5 min read
Graphic: Erica P. Johnson German plant biotechnology companies, frustrated by a European moratorium and lacking political and public support in their home country, struggle to sustain their re-search. Many still hope that genetically modified (GM) plant products will eventually find their way to the market. Some officials even believe that green gene technology, as plant genetics are sometimes called, could become a cornerstone in the recovery of the eastern German economy. Basic academic res
Bedeviled by Dengue
Beth Marie Mole | Mar 1, 2013 | 10+ min read
The global spread of dengue virus has immunologists and public-health experts debating the best way to curb infection.
Back to Africa
Sam Jaffe | Nov 24, 2002 | 7 min read
Photo: Courtesy of Special Programme for Research and Training in Tropical Diseases SCIENTIST IN ISOLATION: African researchers, like this technician at the University of Khartoum, struggle to collaborate with other scientists. The release of the decoded genome for Plasmodium falciparum (the most deadly malaria parasite) in October represented a momentous step forward for the people of Africa. Around the same time, Abdoulaye Djimde, the head of the epidemiology and immunology department a
2020 Top 10 Innovations
The Scientist | Dec 1, 2020 | 10+ min read
From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.
The Heart of Europe's Biotech Sector
Martina Habeck | Aug 1, 2004 | 6 min read
More than 5,000 scientists with higher academic degrees work in public research in Europe's Upper Rhine valley, making this area one of the highest densities of life sciences-related research in the world. Now, the triangle region from Basel, Switzerland, in the south to Strasbourg, France, and Freiburg, Germany, in the north is striving to become the European heart of the biotechnology sector.The Dreiländereck or la Régio, as the region is called locally, has a lot going for it: excel
scientific conferences meeting coronavirus covid-19 sars-cov-2
Life Science Conference Disruptions Due to Coronavirus
The Scientist | Mar 5, 2020 | 8 min read
Find out which meetings have been canceled, postponed, or are going ahead as planned.
Bioterrorism Research: New Money, New Anxieties
John Dudley Miller | Apr 6, 2003 | 8 min read
Ned Shaw US scientists have reason to feel both heady and scared. The federal government recently released unprecedented billions of dollars to fund bioterrorism research. Yet, the merits of this sudden shift in focus are being debated, and some worry that the money will be squandered or wasted. "I have been really very upset by the focus on bioterrorism," says Stanley Falkow, professor of microbiology and immunology and of medicine at Stanford University. "Everybody's talking about it, but th
How Orphan Drugs Became a Highly Profitable Industry
Diana Kwon | May 1, 2018 | 10+ min read
Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.

Run a Search

ADVERTISEMENT